☆ 4.7 Letter

Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myeloma

BLOOD (2018)

Get Full Text
Add to Collection

Journal

BLOOD
Volume 132, Issue 19, Pages 2097-2100

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2018-05-851170

Keywords

-

Categories

Hematology

Funding

  1. Swiss Group for Clinical Cancer Research (SAKK)
  2. Swiss State Secretariat for Education, Research and Innovation (SERI)
  3. Rising Tide Foundation for Clinical Cancer Research
  4. Gateway for Cancer Research

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.